|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Clinical Biochemistry (Dr. Ennis and Ms. Brown), Queens University of Belfast; Department of Respiratory Medicine (Drs. Kelly and Elborn), Belfast City Hospital; and Division of Biomedicinal Chemistry (Dr. Martin), School of Pharmacy, Queens University of Belfast, Belfast, Northern Ireland.
Correspondence to: Martin G. Kelly, MB, BCH, BAO, Specialist Registrar, Department of Respiratory Medicine, Level 11 Office, Belfast City Hospital, Lisburn Rd, Belfast BT9 7AB, Northern Ireland; e-mail: m.g.kelly{at}qub.ac.uk
Study objectives: Induced sputum is used to investigate pulmonary diseases. Low-output ultrasonic nebulizers have become available and have potential advantages over high-output nebulizers. We hypothesized that a low-output nebulizer would give comparable results to a high-output nebulizer, with an acceptable safety profile.
Design: Randomized, crossover study.
Setting: University teaching hospital.
Participants: Ten normal subjects and 10 patients with COPD.
Interventions: Participants attended for sputum induction on two occasions in random order using low-output and high-output nebulizers.
Measurements and results: Lung function and oxygen saturation were measured during sputum induction, and tolerability of the procedure was assessed. Cell counts, interleukin 8, and neutrophil elastase were measured in sputum. Use of the high-output nebulizer resulted in a greater FEV1 (mean ± SEM, 0.29 ± 0.04 L vs 0.21 ± 0.04 L; p = 0.04) and percentage drop in FEV1 (25.8 ± 2.6% vs 19.5 ± 2.9%, respectively; p = 0.02) compared with the low-output nebulizer in patients with COPD. There was a shorter tolerated nebulization time with the high-output nebulizer compared with the low-output nebulizer: 12.7 ± 2.0 min vs 16.5 ± 1.8 min, respectively (p = 0.02). Modified Borg scores were lower with the low-output nebulizer than the high-output nebulizer in normal subjects: median, 0 (interquartile range [IQR], 0 to 1) vs median, 1.5 (IQR, 0 to 2), respectively (p = 0.05). There were no differences in cell counts and soluble markers of inflammation.
Conclusions: The low-output ultrasonic nebulizer is comparable to high-output nebulizer for cellular and soluble markers of inflammation, results in a smaller reduction in FEV1, is better tolerated, and is a suitable tool for investigating airway inflammation in patients with COPD.
Key Words: COPD induced sputum ultrasonic nebulizer
This article has been cited by other articles:
![]() |
A P Watt, J Courtney, J Moore, M Ennis, and J S Elborn Neutrophil cell death, activation and bacterial infection in cystic fibrosis Thorax, August 1, 2005; 60(8): 659 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
A P Watt, V Brown, J Courtney, M Kelly, L Garske, J S Elborn, and M Ennis Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis Thorax, March 1, 2004; 59(3): 231 - 236. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |